NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Vedanta Share Price Jumps 5.3% on NCD Fundraise Approval

On February 25, 2026, Vedanta's share price surged 5.3% to reach an intra-day high of ₹732 on the BSE following the approval of a ₹3,000 crore fundraise via non-convertible debentures (NCDs).

In a regulatory filing, Vedanta announced that its board-constituted Committee of Directors has approved the issuance of unsecured, rated, listed, and redeemable NCDs on a private placement basis. The proposed issuance will comprise up to 3,00,000 NCDs, each with a face value of ₹1,00,000, taking the total issue size to ₹3,000 crore.

The bonds will be issued on a private placement basis, and the approval was granted at the committee meeting held earlier in the day. The ₹3,000 crore fundraise is expected to provide a boost to the company's financials and support its future growth initiatives.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Investor Takeaway

Investors should be aware of Vedanta's potential for short-term market volatility following the approval of a ₹3,000 crore fundraise.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.